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The Korean Society of Nephrology (KSN) launched a nationwide ofﬁcial survey
program about dialysis therapy in 1985. Nowadays, the accumulated data for 30
years by this “Insan Prof. Min Memorial end-stage renal disease (ESRD) Registry”
program have been providing the essential information for dialysis clinical practice,
academic nephrology research, and health management policy. We reviewed 30
years of data to identify important changes and implications for the future
improvement of dialysis therapy in Korea.
Hemodialysis patients, especially diabetics and elderly patients have increased in
number very rapidly during recent years in Korea. The Korean prevalence rate of
ESRD patients was about 70% of the United States and about 50% of Japan according
to the international comparisons in the annual data report of United States Renal
Data System. The blood pressure control, anemia control, and dialysis adequacy
have continuously improved year by year. The importance of calcium and phos-
phorus control has also been increasing because of the increase in long-term
dialysis patients. In addition, chronic dialysis complications should be closely
monitored and dialysis modiﬁcations, such as hemodiaﬁltration therapy, might be
considered. Because of the increase of private clinics and nursing hospitals in
dialysis practice, the role of dialysis specialists and continuing education are
thought to be essential. For strict cost-effective dialysis control of increasing elderly,
diabetic, and long-term dialysis patients, the KSN ESRD patient registration should
be run by the KSN and health ministry in cooperation, in which the dialysis fee
reimbursement should be accompanied.
Copyright & 2015. The Korean Society of Nephrology. Published by Elsevier. This is an
open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).15. The Korean Society of Nep
.org/licenses/by-nc-nd/4.0/).
al Medicine, St. Vincent’s
Jungbu-daero, Paldal-gu,
n).Introduction
The number of end-stage renal disease (ESRD) patients under-
going maintenance dialysis therapy has increased very rapidly in
recent decades because of the increase of elderly population andhrology. Published by Elsevier. This is an open access article under the
Jin et al / Lessons from Korean ESRD registry 133diabetic patients all over the world. Maintenance dialysis for ESRD
is one of typical therapies for long-term vital organ replacement,
which is considered as the most cost-consuming treatment in
current medical practice. For adequate supply of dialysis facilities
and proper management of dialysis therapy itself, nationwide
statistical data and analysis are essential.
In Korea, the ﬁrst nationwide survey on dialysis was per-
formed by the late Professor Byung-Suk Min in 1980 and was
published in the ﬁrst issue of Korean Journal of Nephrology, which
was previously the ofﬁcial journal of the Korean Society of
Nephrology (KSN) [1]. The KSN launched a nationwide ofﬁcial
survey program about dialysis therapy in 1985. Nowadays, the
accumulated data for 30 years by this “Insan Prof. Min Memorial
ESRD Registry” program have been providing essential informa-
tion for dialysis clinical practice, academic nephrology research,
and health management policy [2,3].
We reviewed 30 years of data to identify important changes and
implications for the future improvement of dialysis therapy in Korea.Development of the registry process
From 1985 to 1994, a printed questionnaire was posted to
every dialysis center in Korea, mainly university hospitals, and
replied mails were also posted back to the KSN ofﬁce. As personal
computers were used in most hospitals, the KSN developed an
electronic questionnaire about dialysis in 1995 and posted it on a
diskette to every dialysis center. The replies were also posted on
diskettes or transmitted via electronic ﬁle transfer through a dial-
up modem. An Internet questionnaire was developed in 2001,
which was completely revised in 2013 for updates of dialysis
therapy and data security. Currently, the Internet questionnaire
includes dialysis center information, patient personal medical
information, vascular access, dialysis adequacy performance data,
medications including erythropoietin (EPO) and phosphate bin-
ders, rehabilitation status, and laboratory data. The program also
has a graphic evaluation function of dialysis adequacy: single-pool
Kt/V, normalized protein catabolic rate, and a peritoneal equili-
brium test. The data were collected on the KSN Web page
throughout the year (Table 1). Every KSN member can access
the dialysis adequacy data of their own dialysis center anytime,
which could be of some help for dialysis prescriptions. The
average KSN ESRD registry response rate of the past 3 years
was about 70%. The annual survey results have been reported at
the autumn meeting of the KSN and on the KSN Web page, and
currently reported at the spring KSN meeting since 2014.Dialysis data from the KSN ESRD registry
Prevalence and incidence of ESRD
At the end of 2014, the number of ESRD patients in Korea
was reported as 80,674, in which 57,256 were hemodialysisTable 1. Brief history of Korean end-stage renal disease registry
Period Data collection method
1985–1994 Post mail with paper questionnaire
1995–2000 Electronic questionnaire, dial-up modem ﬁle transfe
or diskette mailing
2001–2012 Internet online questionnaire, password
2013–current Internet online questionnaire with data security pro(HD) patients, 7,423 were peritoneal dialysis (PD) patients, and
15,995 were kidney transplantation (KT) patients. The patient
per million population was 1,115 HD, 145 PD, 311 KT, and
overall 1,572 [4]. In addition, the proportions of HD, PD, and KT
in renal replacement modalities were 71%, 9%, and 20%,
respectively, at the end of 2014 (Fig. 1A).
The Korean prevalence rate of ESRD patients was about 70%
of the United States and about 50% of Japan according to the
international comparisons in the annual data report of United
States Renal Data System (USRDS) [5,6]. The increase of the
number of HD patients was still high at 9% per year, but there
was nearly no increase in the number of PD patients in
recent years.
The number of new patients with dialysis initiation in 2014
was estimated to be 11,461 (10,594 HD, 867 PD, overall 213
patients per million population).
Underlying causes of ESRD
The most common underlying cause of ESRD is diabetic
nephropathy, which was 48% in new ESRD patients in 2014.
Other common causes were hypertensive nephrosclerosis
(21.2%) and chronic glomerulonephritis (8.2%). The proportion
of diabetic patients in Korea was the highest in the world,
except for a couple of city states according to international
comparisons in the annual data report of USRDS. The diabetic
proportion rapidly increased from 1990 to 2000 but slowly
increased from 2000 to 2014 in Korea (Fig. 1B).
Dialysis centers and dialysis machines
The number of dialysis centers in Korea was 763, in which
the non-KSN member centers (approximately 40 centers) were
excluded. The number of HD machines was estimated at
21,000 at the end of 2014. The average number of machines
per center was about 28, and the average number of HD
patients per machine was 2.7. About 47% of HD patients were
under maintenance dialysis therapy at private clinics, about
36% patients were at a general hospital, and about 17% of
patients were at a university hospital. The proportion of
general hospitals increased because of the increase of dialysis
centers for elderly patients in nursing hospitals.
Dialysis patient characteristics
Sex ratio
The sex ratio (male vs. female) was 58%:42% in HD patients
and 56%:44% in PD patients. The number of male patients was
much higher than the number of female patients compared
with the general population. These ratios had no interval
change during 20 years and were quite similar to those of
the United States.Information
Dialysis center & basic personal data
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Figure 1. Dialysis prevalence. (A) The number of patients with renal replacement therapy at the end of each year. (B) Changes in the proportion of
three major causes of end-stage renal disease. (C) Age distribution of dialysis patients according to underlying diseases. (D) Duration of maintenance
HD and PD. Percent of estimated patient number according to year. (E) Distribution of mean arterial pressure in HD and PD patients. Blood pressure
was higher in HD patients than in PD patients. (F) Systolic and diastolic blood pressure with pulse pressure in HD and PD patients.
BP, blood pressure; CGN, chronic glomerulonephritis; DM, diabetic nephropathy; HD, hemodialysis; HTN, hypertensive nephrosclerosis; KT, kidney
transplantation; MAP, mean arterial pressure; PD, peritoneal dialysis.
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The ratio of ABO blood type (A:B:AB:O) was 35%:27%:11%:27%,
which was the same as the general population.Hepatitis B and C
Hepatitis B antigen positivity was 6% and hepatitis C anti-
body positivity was 4% in HD patients in 2014. The percentages
in PD patients were 6% and 3%, respectively.Medical insurance status
About 76% of dialysis patients were covered by national
health insurance and 20% were under medical aid programs in
Korea at the end of 2014.Age
The average age of overall dialysis patients was 60.3714.1
years, which had steadily increased from 55.2 years in 2005.
The average age of HD patients was 61.1713.8 years and
55.4 714.5 years in PD patients. The percentage of elderly
patients (over 65 years) was 40.7% in 2014, which had increased
from 28% in 2005. The average age of diabetic dialysis patients
was 62.7712.2 years, hypertensive nephrosclerosis patients was
61.5713.9 years, and chronic glomerulonephritis patients
was 54.5715.0 years in 2014 (Fig. 1C).Duration of dialysis maintenance
About 21% of HD patients were under dialysis therapy for
more than 10 years, and 27% of HD patients were under 5–10
years, and 11% were under less than 1 year of dialysis therapy.
Among PD patients, only 15% were under dialysis for more
than 10 years. In addition, about 11% of diabetic HD patients
were under dialysis for more than 10 years, but 29% of
nondiabetic HD patients were under dialysis for more than
10 years. These data suggested that the survival of HD patients
and nondiabetic patients is longer than that of PD patients and
diabetic patients (Fig. 1D).Body mass index
The average of body mass index (the body weight in
kilogram divided by square of the body height in meters) of
HD patients was 22.274.1 kg/m2 and that of PD patients was
24.275.1 kg/m2 in 2014. These were also steadily increased
from 21.4 kg/m2 and 23.2 kg/m2 in 2005.Blood pressure
The mean arterial pressure of HD patients was 100.07
12.2 mmHg and that of PD patients was 97.9713.7 mmHg in
2014. These mean arterial pressures decreased from 104.9
mmHg and 100.4 mmHg in 2005. The mean pulse pressure
of HD patients was 65.2717.3 mmHg, which was much higher
than that of PD patients, 53.7713.6 mmHg (Figs. 1 E and 1F).
Dialysis therapy characteristics
Frequency of HD and hemodiaﬁltration (HDF). About 91% of
HD patients were on a three times/wk schedule and only 7% of
patients were on a twice/wk schedule. The percentage had
minimally changed from 2005. HDF therapy was still not
popular and was provided to only 15% of HD patients.Dialyzer and dialysate
The surface area of dialyzer had been slowly increasing, but
only 50% of HD patients were under dialysis with a less than
1.5 m2 dialyzer, and a 1.5 m2 to 2.0 m2 dialyzer was used for
44% of HD patients. The bicarbonate dialysate was used
for about 97% of HD patients, dialysate with glucose was used
for 65% of HD patients, and low calcium dialysate was used for
6% of HD patients.
Vascular access
The autologous arteriovenous ﬁstula was used in 76% of HD
patients, arteriovenous graft shunt was used in 15%, and
subcutaneous tunneled catheter was used in 7% of HD
patients. About 46% of HD patients had the arteriovenous
ﬁstula on the left forearm and 18% had ﬁstula on the left upper
arm in 2014 (Fig. 2A).
PD catheters
About 42% of PD patients had swan neck PD catheters and
22% had swan neck with coiled tip PD catheters in 2014. The
PD catheter was inserted by surgical method in 64% and by
trocar method in 28% of newly started PD patients in 2014. The
break-in period of the PD catheter was mostly 2–3 weeks
(32%) (Fig. 2B).
PD type and doses
The automated PD program was applied to about 26% of PD
patients in 2014. About 52% of PD patients had used 8–10 L/d
of dialysate.
Anemia and EPO therapy
The mean hemoglobin level of HD patients was 10.477
1.15 g/dL and that of PD patients was 10.3771.39 g/dL in 2014.
More than 12,000 units/wk of EPO was injected to 30%
of HD patients, but only 14% of HD patients had not used
EPO. In PD patients, only 23% of patients had used more than
12,000 units/wk of EPO and 19% of patients had no EPO
(Figs. 2C and 2D). Darbepoetin (Nesp®) and methoxy poly-
ethylene glycol-epoetin beta (Mircera®) were calculated with
conversion factor of EPO.Calcium and phosphorus control
The mean calcium level of HD patients was 8.8970.87 mg/dL
and that of PD patients was 8.6570.97 mg/dL in 2014. The mean
phosphorus level of HD patients was 4.9171.64 mg/dL and
that of PD patients was 5.1471.68 mg/dL (Fig. 2E). The average
parathyroid hormone (PTH) level of HD patients was
2207235 pg/mL, but the distribution of PTH levels showed
extreme skewness at right tail distribution: most frequent value
was about 30–100 pg/mL.
Calcium carbonate or calcium acetate was applied to 66% of
HD patients, and sevelamer or lanthanum was applied to 13%
of HD patients as phosphate binders. For PTH control, about
24% of HD patients were prescribed vitamin D, and cinacalcet
was prescribed to only 2% of HD patients (Fig. 2F).Miscellaneous laboratory data
The average albumin level of HD patients was 3.887
0.46 g/dL and that of PD patients was 3.5270.51 g/dL in 2014.
The average creatinine level of HD patients was 9.173.0 mg/dL
and that of PD patients was 10.474.1 mg/dL. The average total
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Kidney Res Clin Pract 34 (2015) 132–139136cholesterol level of HD patients was 144.7735.7 mg/dL and that
of PD patients was 161.8741.7 mg/dL. The average uric acid
level of HD patients was 7.171.7 mg/dL and that of PD patientswas 6.871.7 mg/dL. The average hemoglobin A1c level of
diabetic HD patients was 6.971.5% and that of diabetic PD
patients was 6.671.5%.
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Figure 3. Dialysis adequacy, rehabilitation, and survival. (A) Distribution of URR in HD patients. (B) Distribution of patient numbers according to
nPCR and single-pool Kt/V in HD patients. (C) Rehabilitation status of HD and PD patients. (D) Patient survival according to underlying diseases
since 2001.
DM, diabetic nephropathy; GN, glomerulonephritis; HD, hemodialysis; HTN, hypertensive nephrosclerosis; Misc, miscellaneous; nPCR, normalized
protein catabolic rate; PD, peritoneal dialysis; URR, urea reduction ratio.
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The overall urea reduction ratio of HD patients was
71.477.0 in 2014. The average urea reduction ratio of male
HD patients was 68.976.4%, and that of female patients was
75.076.1%, which had been steadily increasing from 63.6%
and 70.4% in male and female patients in 2001 (Fig. 3A). The
normalized protein catabolic rate of HD patients had minimal
interval change during 2001–2014 (men, from 0.90 to 0.91;
women, from 1.05 to 1.02), but single-pool Kt/V had steadily
increased (men, from 1.05 to 1.42; women, from 1.53 to 1.69)
(Fig. 3B).Rehabilitation, comorbidity, and causes of death
At the end of 2014, about 31% of PD patients had a full time
job, but only 21% of HD patients had a full time job. On thecontrary, 17% of HD patients and 13% of PD patients were
dependent in daily living or bed ridden state. The most
common comorbidity was reported in 2014 as vascular dis-
eases, which was present in 48.3% of HD patients and 56.8% of
PD patients. Coronary artery disease was also present in 9.3%
of HD patients and 7.4% of PD patients (Fig. 3C). The most
common cause of death in HD patients was cardiac (32%), and
the next common cause was infection (26%). In PD patients,
cardiac death occurred in 34% and death due to infection
occurred in 33% in 2014.Survival of dialysis patients
The 5-year patient survival rate since 2001 was 68.7% in
men and 71.8% in women. The 5-year diabetic patient survival
rate was about 60.0% (Fig. 3D).
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The size of the KSN registry data has grown 35 times in the
last 30 years, in which the data on 1,800 dialysis patients in
1985 and the data on 64,000 dialysis patients in 2014 had been
included [2–4]. The annual growth rate of the number of
dialysis patients was as high as 9% in recent several years
according to the expansion of diabetic patients and elderly
population. The overall cost for dialysis has also rapidly
increased; the cost in Korea was estimated to be 1,600 billion
Korean won ($1.5 billion) in 2013 according to the health
insurance review and assessment service report, and the cost
in the USA was $34.3 billion in 2011 according to the USRDS
report. A nationwide special dialysis therapy administrative
bureau with dialysis patient registration program and dialysis
specialist group is thought to be necessary for the adequate
administration of this rapidly expanding dialysis therapy in the
long-term perspective.
The population of diabetic patients is still rapidly increasing
in Korea according to the Korean Diabetes Association’s survey,
so the diabetic proportion of dialysis patients is expected to
grow continuously during the next several years. Moreover,
because diabetic dialysis patients are usually involved in
multiple serious diabetic complications other than diabetic
nephropathy, such as ischemic heart disease, diabetic retino-
pathy, and peripheral neuropathy, the care of a diabetic
dialysis patient is a very huge medical burden to the medical
personnel in a dialysis unit. More strict control of diabetic
patients with cooperation of endocrinologists and nephrolo-
gists is necessary for the reduction of the prevalence of
diabetic nephropathy.
In contrast to the rapid increase of HD patients, the number
of PD patients had not increased and even decreased in the last
several years. This ﬁnding was also seen in the United States,
but the number of PD patients increased in some countries,
such as Hong Kong and Mexico, in which PD therapy was
forcefully driven by the health ministry [5]. The guidelines or
recommendations on dialysis therapy choice for Korean
patients will be helpful for initial dialysis modality choice.
In the aspect of dialysis facilities, the proportion of private
clinics in dialysis therapy has increased. The reason is
thought to be that dialysis therapy has become quite a safe
and popular medical procedure, and the stable long-term
dialysis maintenance patient population has increased.
Another aspect of dialysis facilities was the expansion of
nursing hospitals for elderly patients with dialysis centers.
Recently, owing to the increase of elderly dialysis patients,
hundreds of nursing hospitals started to run afﬁliated dialysis
facilities, in which nephrologic care was often insufﬁcient.
Therefore, the continuing education and evaluation of dialysis
personnel in private clinics and nursing hospitals should be
mandatory.
About half of dialysis patients were under dialysis for more
than 10 years. These long-term dialysis patients should be
evaluated and monitored for chronic dialysis complications. Some
dialysis modiﬁcations, such as HDF therapy, might be considered
for the prevention of long-term dialysis complications.
Blood pressure control, anemia control, and dialysis ade-
quacy have continuously improved in dialysis therapy in
Korea. However, multiple high dose antihypertensive, high
dose EPO, and expensive high performance dialyzer were
needed for these improvements. The importance of calcium
and phosphorus control also has been increasing according tothe increase of long-term dialysis patients. However, the cost-
effectiveness evaluation on these controls might be needed
because of recently introduced high-priced phosphate binders,
vitamin D, and calcimimetics.
The reported patient survival rate of KSN registration data
was much higher than that in other countries, such as Japan
and the United States. These high patient survival rates were
due to low registration rate (about 70%) and missed death
reports. This ﬁnding is another important reason why the KSN
ESRD patient registration should be run by the KSN and health
ministry together, by which the dialysis fee reimbursement
should be accompanied.Conclusion
We, the KSN ESRD registry committee, have performed the
dialysis patient registration and reported for 30 years. HD
patients, especially the diabetics and elderly patients, have
increased in number very rapidly during recent several years
in Korea. As the patient population increase, the medical cost
for dialysis has also increased. To reduce this burden, diabetic
nephropathy care and elderly patient care should be
emphasized.
Anemia, high blood pressure, and dialysis adequacy have
gradually improved by high-dose EPO therapy, multiple anti-
hypertensives, and high performance dialyzer, respectively,
but the cost-effectiveness of these therapies should be eval-
uated. Because the long-term dialysis patient population has
increased, chronic dialysis complications should be closely
monitored and dialysis modiﬁcations, such as HDF therapy,
might be considered. Because of the increase of private clinics
and nursing hospitals in dialysis practice, the role of the
dialysis specialist and continuing education are thought to be
essential.
For strict cost-effective dialysis control of increasing elderly,
diabetic, and long-term dialysis patients, the KSN ESRD patient
registration should be run jointly by the KSN and health
ministry, by which the dialysis fee reimbursement should be
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